These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4607196)

  • 21. Brain-stimulation reward: current issues and future prospects.
    Phillips AG; Mogenson GJ
    Can J Psychol; 1978 Jun; 32(2):124-8. PubMed ID: 737576
    [No Abstract]   [Full Text] [Related]  

  • 22. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.
    Chiu S; Mishra RK
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(1):45-50. PubMed ID: 6111027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minor tranquillizers, stress and central catecholamine neurons.
    Corrodi H; Fuxe K; Lidbrink P; Olson L
    Brain Res; 1971 Jun; 29(1):1-16. PubMed ID: 5564261
    [No Abstract]   [Full Text] [Related]  

  • 25. Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems.
    Bartholini G; Scatton B; Worms P; Zivkovic B; Lloyd KG
    Adv Biochem Psychopharmacol; 1981; 30():119-28. PubMed ID: 6120626
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence for a prime role of newly synthesized dopamine in mesolimbic dopamine areas.
    Sears ES; Shore PA
    J Pharm Pharmacol; 1975 Sep; 27(9):718-20. PubMed ID: 241823
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of clozapine on cerebral catecholaminergic neurone systems.
    Bartholini G; Haefely W; Jalfre M; Keller HH; Pletscher A
    Br J Pharmacol; 1972 Dec; 46(4):736-40. PubMed ID: 4676274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of typical and atypical neuroleptics on the behavioural consequences of activation by muscimol of mesolimbic and nigro-striatal dopaminergic pathways in the rat.
    Oakley NR; Hayes AG; Sheehan MJ
    Psychopharmacology (Berl); 1991; 105(2):204-8. PubMed ID: 1686655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on the extrapyramidal system from the standpoint of pharmacology and psychopharmacology].
    Hara S
    Zasshi Tokyo Ika Daigaku; 1969 Jan; 27(1):1-22. PubMed ID: 4978901
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of telencephalic dopaminergic systems in the mediation of apomorphine-stereotyped behaviour.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1973 Oct; 24(1):8-24. PubMed ID: 4796448
    [No Abstract]   [Full Text] [Related]  

  • 31. [Recent data on the mode of action of neuroleptics].
    Bartholini G
    Actual Pharmacol (Paris); 1978; 30():35-47. PubMed ID: 28640
    [No Abstract]   [Full Text] [Related]  

  • 32. Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system.
    Bartholini G
    J Pharm Pharmacol; 1976 May; 28(5):429-33. PubMed ID: 6752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The site and mode of action of ET495 for the mediation of stereotyped behaviour in the rat.
    Costall B; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(2):117-33. PubMed ID: 4268638
    [No Abstract]   [Full Text] [Related]  

  • 34. Cholinergic- and neuroleptic-induced catalepsy: modification by lesions in the caudate-putamen.
    Costall B; Olley JE
    Neuropharmacology; 1971 May; 10(3):297-306. PubMed ID: 5104497
    [No Abstract]   [Full Text] [Related]  

  • 35. Phencyclidine-induced rotational behavior in rats with nigrostriatal lesions and its modulation by dopaminergic and cholinergic agents.
    Finnegan KT; Kanner MI; Meltzer HY
    Pharmacol Biochem Behav; 1976 Dec; 5(6):651-60. PubMed ID: 15284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of the push-pull cannula to estimate the dynamics of acetylcholine and catecholamines within various brain areas.
    Bartholini G; Stadler H; Ciria MG; Lloyd KG
    Neuropharmacology; 1976 Sep; 15(9):515-9. PubMed ID: 980227
    [No Abstract]   [Full Text] [Related]  

  • 37. Does dopamine play a role in schizophrenia?
    Carlsson A
    Psychol Med; 1977 Nov; 7(4):583-97. PubMed ID: 22890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons.
    Andén NE; Corrodi H; Fuxe K; Ungerstedt U
    Eur J Pharmacol; 1971 Jul; 15(2):193-9. PubMed ID: 4341651
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs.
    Sharman DF
    Br J Pharmacol Chemother; 1966 Nov; 28(2):153-63. PubMed ID: 5972623
    [No Abstract]   [Full Text] [Related]  

  • 40. delta9-Tetrahydrocannabinol and the extrapyramidal system.
    Gough AL; Olley JE
    Psychopharmacology (Berl); 1977 Aug; 54(1):87-99. PubMed ID: 410052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.